Nasdaq

Adocia Announces Positive Clinical Results Confirming the Ultra-Rapid Profile of a BioChaperone® Lispro Formulation Containing Insulin from Partner Tonghua Dongbao

LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Paris:ADOC) (Euronext Paris: FR0011184241 – ADOC, the “Company”), the biopharmaceutical company focused on the treatment of diabetes and other ...
JD Supra

FDA Approves LYUMJEV (insulin lispro-aabc injection)

This week, the FDA approved LYUMJEV (insulin lispro-aabc), a new insulin lispro product by Lilly. LYUMJEV is a formulation of insulin lispro, developed to speed the absorption of insulin into the ...
Yahoo Finance

Adocia’s partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial to Treat Type 1 and Type 2 Diabetes in China

This Phase 3 clinical program will enroll over 1,300 people with diabetes and is expected to be pivotal for product registration in China First patient in the study will trigger a milestone payment to ...
Medindia

Humalog (3 ml) (Insulin Lispro) Drug Price and Information

Insulin Lispro (Humalog (3 ml)) is a fast acting insulin analogue, prescribed for type 1 diabetes. The information provided on this page is intended to serve as a comprehensive resource and should not ...
Business Wire

Adocia and Lilly Announce Positive Topline Results from a Phase 1b Study of Repeated Administration of Ultra-Rapid BioChaperone Lispro U100 in People with Type 2 Diabetes

LYON, France & INDIANAPOLIS--(BUSINESS WIRE)--Regulatory News: Adocia (Paris:ADOC) and Eli Lilly and Company (NYSE: LLY) announced today positive topline results from a Phase 1b clinical trial under ...
Medindia

Humalog (3ml) (Insulin Lispro) Drug Price and Information

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Insulin Lispro (Humalog (3ml)) is a fast acting ...